Hepatitis B Immune Globulin Global and China Top Players Market

Hepatitis B Immune Globulin - Global and China Top Players Market Share and Ranking 2025

Hepatitis B Immune Globulin Global and China Top Players Market

Hepatitis B Immune Globulin - Global and China Top Players Market Share and Ranking 2025


The Hepatitis B Immune Globulin Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Hepatitis B Immune Globulin Market Size and Forecast 2024 to 2031

• The global Hepatitis B Immune Globulin market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Hepatitis B Immune Globulin market is expected to reach the value of US$ XX Million by the end of 2031

Hepatitis B Immune Globulin Market Overview
Hepatitis B immune globulin (HBIG) is a type of blood product made from human plasma that contains antibodies against the hepatitis B virus. It is typically given by injection and is used to prevent or treat hepatitis B infection



This report studies and analyses global Hepatitis B Immune Globulin status and future trends, helping the client to determine the Hepatitis B Immune Globulin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Hepatitis B Immune Globulin. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.

Hepatitis B Immune Globulin Market Key Takeaways

(1) Global Hepatitis B Immune Globulin market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Hepatitis B Immune Globulin sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Hepatitis B Immune Globulin sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Hepatitis B Immune Globulin key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Hepatitis B Immune Globulin key producing regions, capacity, production, and year-over-year growth
(6) Hepatitis B Immune Globulin industry chains, upstream, midstream, and downstream

Hepatitis B Immune Globulin Market: Key Players

The competitive landscape of the Hepatitis B Immune Globulin Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Hepatitis B Immune Globulin Market. Some of the major players operating in the Hepatitis B Immune Globulin Market are:
  • ADMA Biologics
  • Bio Products Laboratory
  • Grifols
  • Biotest AG
  • CSL Behring
  • FFF Enterprises
  • Cleveland Clinic


Market IntelliX's study on the Hepatitis B Immune Globulin market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Hepatitis B Immune Globulin Market by Type [Analysis by Value from 2020 to 2031]:
  • Intravenous Injection
  • Intramuscular Injection


Hepatitis B Immune Globulin Market by Application [Analysis by Value from 2020 to 2031]:
  • Liver Transplant Patients
  • Newborn Baby
  • Others


Hepatitis B Immune Globulin Market by Region [Analysis by Value from 2020 to 2031]:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


Hepatitis B Immune Globulin Market Report Includes:

Chapter 1: To describe Hepatitis B Immune Globulin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Hepatitis B Immune Globulin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 3: China Hepatitis B Immune Globulin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 4: Global key producing regions of Hepatitis B Immune Globulin , percent & CAGR, 2020 - 2031

Chapter 5: Hepatitis B Immune Globulin industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Hepatitis B Immune Globulin Definition

1.2 Global Hepatitis B Immune Globulin Market Size and Forecast

1.2.1 By Consumption Value, Global Hepatitis B Immune Globulin Market Size, 2020-2031

1.2.2 By Sales Quantity, Global Hepatitis B Immune Globulin Market Size, 2020-2031

1.2.3 Global Hepatitis B Immune Globulin Average Selling Price (ASP), 2020-2031

1.3 China Hepatitis B Immune Globulin Market Size and Forecast

1.3.1 By Consumption Value, China Hepatitis B Immune Globulin Market Size, 2020-2031

1.3.2 By Sales Quantity, China Hepatitis B Immune Globulin Market Size, 2020-2031

1.3.3 China Hepatitis B Immune Globulin Average Selling Price (ASP), 2020-2031

1.4 Share of China Hepatitis B Immune Globulin Market with Respect to the Global Market

1.4.1 By Consumption Value, China Hepatitis B Immune Globulin Market Share in Global, 2020-2031

1.4.2 By Sales Quantity, China Hepatitis B Immune Globulin Market Share in Global, 2020-2031

1.4.3 Hepatitis B Immune Globulin Market Size: China VS Global, 2020-2031

1.5 Hepatitis B Immune Globulin Market Dynamics

1.5.1 Hepatitis B Immune Globulin Market Drivers

1.5.2 Hepatitis B Immune Globulin Market Restraints

1.5.3 Hepatitis B Immune Globulin Industry Trends

1.5.4 Hepatitis B Immune Globulin Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Hepatitis B Immune Globulin, Global Market Share by Company, 2020-2025

2.2 By Sales Quantity of Hepatitis B Immune Globulin, Global Market Share by Company, 2020-2025

2.3 Hepatitis B Immune Globulin Average Selling Price (ASP) by Company, 2020-2025

2.4 Global Hepatitis B Immune Globulin Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Hepatitis B Immune Globulin Concentration Ratio

2.6 Global Hepatitis B Immune Globulin Mergers & Acquisitions, Expansion Plans

2.7 Global Hepatitis B Immune Globulin Manufacturers Product Type

2.8 Head Office and Hepatitis B Immune Globulin Production Site of Key Manufacturer

2.9 Hepatitis B Immune Globulin Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Hepatitis B Immune Globulin, China Market Share by Company, 2020-2025

3.2 By Sales Quantity of Hepatitis B Immune Globulin, China Market Share by Company, 2020-2025

3.3 China Hepatitis B Immune Globulin Hepatitis B Immune Globulin Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Hepatitis B Immune Globulin Capacity, Output and Capacity Utilization, 2020-2031

4.2 Global Hepatitis B Immune Globulin Capacity by Region

4.3 Global Hepatitis B Immune Globulin Production & Forecast by Region, 2020 VS 2024 VS 2031

4.4 Global Hepatitis B Immune Globulin Production by Region, 2020-2031

4.5 Global Hepatitis B Immune Globulin Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis

5.1 Hepatitis B Immune Globulin Industry Chain

5.2 Hepatitis B Immune Globulin Upstream Analysis

5.2.1 Hepatitis B Immune Globulin Core Raw Materials

5.2.2 Main Manufacturers of Hepatitis B Immune Globulin Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Hepatitis B Immune Globulin Production Mode

5.6 Hepatitis B Immune Globulin Procurement Model

5.7 Hepatitis B Immune Globulin Industry Sales Model and Sales Channels

5.7.1 Hepatitis B Immune Globulin Sales Model

5.7.2 Hepatitis B Immune Globulin Typical Distributors

6 Sights by Product Type

6.1 Hepatitis B Immune Globulin Classification

6.1.1 Intravenous Injection

6.1.2 Intramuscular Injection

6.2 by Type, Global Hepatitis B Immune Globulin Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Type, Global Hepatitis B Immune Globulin Consumption Value, 2020-2031

6.4 by Type, Global Hepatitis B Immune Globulin Sales Quantity, 2020-2031

6.5 by Type, Global Hepatitis B Immune Globulin Average Selling Price (ASP), 2020-2031

7 Sights by Application

7.1 Hepatitis B Immune Globulin Segment by Application

7.1.1 Liver Transplant Patients

7.1.2 Newborn Baby

7.1.3 Others

7.2 by Application, Global Hepatitis B Immune Globulin Consumption Value & CAGR, 2020 VS 2024 VS 2031

7.3 by Application, Global Hepatitis B Immune Globulin Consumption Value, 2020-2031

7.4 by Application, Global Hepatitis B Immune Globulin Sales Quantity, 2020-2031

7.5 by Application, Global Hepatitis B Immune Globulin Price, 2020-2031

8 Sales Sights by Region

8.1 By Region, Global Hepatitis B Immune Globulin Consumption Value, 2020 VS 2024 VS 2031

8.2 By Region, Global Hepatitis B Immune Globulin Consumption Value, 2020-2031

8.3 By Region, Global Hepatitis B Immune Globulin Sales Quantity, 2020-2031

8.4 North America

8.4.1 North America Hepatitis B Immune Globulin Market Size & Forecasts, 2020-2031

8.4.2 By Country, North America Hepatitis B Immune Globulin Market Size Market Share

8.5 Europe

8.5.1 Europe Hepatitis B Immune Globulin Market Size & Forecasts, 2020-2031

8.5.2 By Country, Europe Hepatitis B Immune Globulin Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Hepatitis B Immune Globulin Market Size & Forecasts, 2020-2031

8.6.2 By Country/Region, Asia Pacific Hepatitis B Immune Globulin Market Size Market Share

8.7 South America

8.7.1 South America Hepatitis B Immune Globulin Market Size & Forecasts, 2020-2031

8.7.2 By Country, South America Hepatitis B Immune Globulin Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Hepatitis B Immune Globulin Market Size & CAGR, 2020 VS 2024 VS 2031

9.2 By Country, Global Hepatitis B Immune Globulin Consumption Value, 2020-2031

9.3 By Country, Global Hepatitis B Immune Globulin Sales Quantity, 2020-2031

9.4 United States

9.4.1 United States Hepatitis B Immune Globulin Market Size, 2020-2031

9.4.2 by Type, United States Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.4.3 by Application, United States Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.5 Europe

9.5.1 Europe Hepatitis B Immune Globulin Market Size, 2020-2031

9.5.2 by Type, Europe Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.5.3 by Application, Europe Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.6 China

9.6.1 China Hepatitis B Immune Globulin Market Size, 2020-2031

9.6.2 by Type, China Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.6.3 by Application, China Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.7 Japan

9.7.1 Japan Hepatitis B Immune Globulin Market Size, 2020-2031

9.7.2 by Type, Japan Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.7.3 by Application, Japan Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.8 South Korea

9.8.1 South Korea Hepatitis B Immune Globulin Market Size, 2020-2031

9.8.2 by Type, South Korea Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.8.3 by Application, South Korea Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.9 Southeast Asia

9.9.1 Southeast Asia Hepatitis B Immune Globulin Market Size, 2020-2031

9.9.2 by Type, Southeast Asia Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.9.3 by Application, Southeast Asia Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.10 India

9.10.1 India Hepatitis B Immune Globulin Market Size, 2020-2031

9.10.2 by Type, India Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.10.3 by Application, India Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.11 Middle East & Africa

9.11.1 Middle East & Africa Hepatitis B Immune Globulin Market Size, 2020-2031

9.11.2 by Type, Middle East & Africa Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

9.11.3 by Application, Middle East & Africa Hepatitis B Immune Globulin Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile

10.1 ADMA Biologics

10.1.1 ADMA Biologics Company Information, Head Office, Market Area, and Industry Position

10.1.2 ADMA Biologics Hepatitis B Immune Globulin Models, Specifications, and Application

10.1.3 ADMA Biologics Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.1.4 ADMA Biologics Company Profile and Main Business

10.1.5 ADMA Biologics Recent Developments

10.2 Bio Products Laboratory

10.2.1 Bio Products Laboratory Company Information, Head Office, Market Area, and Industry Position

10.2.2 Bio Products Laboratory Hepatitis B Immune Globulin Models, Specifications, and Application

10.2.3 Bio Products Laboratory Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.2.4 Bio Products Laboratory Company Profile and Main Business

10.2.5 Bio Products Laboratory Recent Developments

10.3 Grifols

10.3.1 Grifols Company Information, Head Office, Market Area, and Industry Position

10.3.2 Grifols Hepatitis B Immune Globulin Models, Specifications, and Application

10.3.3 Grifols Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.3.4 Grifols Company Profile and Main Business

10.3.5 Grifols Recent Developments

10.4 Biotest AG

10.4.1 Biotest AG Company Information, Head Office, Market Area, and Industry Position

10.4.2 Biotest AG Hepatitis B Immune Globulin Models, Specifications, and Application

10.4.3 Biotest AG Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.4.4 Biotest AG Company Profile and Main Business

10.4.5 Biotest AG Recent Developments

10.5 CSL Behring

10.5.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position

10.5.2 CSL Behring Hepatitis B Immune Globulin Models, Specifications, and Application

10.5.3 CSL Behring Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.5.4 CSL Behring Company Profile and Main Business

10.5.5 CSL Behring Recent Developments

10.6 FFF Enterprises

10.6.1 FFF Enterprises Company Information, Head Office, Market Area, and Industry Position

10.6.2 FFF Enterprises Hepatitis B Immune Globulin Models, Specifications, and Application

10.6.3 FFF Enterprises Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.6.4 FFF Enterprises Company Profile and Main Business

10.6.5 FFF Enterprises Recent Developments

10.7 Cleveland Clinic

10.7.1 Cleveland Clinic Company Information, Head Office, Market Area, and Industry Position

10.7.2 Cleveland Clinic Hepatitis B Immune Globulin Models, Specifications, and Application

10.7.3 Cleveland Clinic Hepatitis B Immune Globulin Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.7.4 Cleveland Clinic Company Profile and Main Business

10.7.5 Cleveland Clinic Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Hepatitis B Immune Globulin Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Hepatitis B Immune Globulin Market trending toward high growth trajectories?
A dynamic process in the Hepatitis B Immune Globulin Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like ADMA Biologics, Bio Products Laboratory, Grifols, Biotest AG, CSL Behring, FFF Enterprises, Cleveland Clinic.
How competitive is the Hepatitis B Immune Globulin Market going to be?
The strategic moves of the Hepatitis B Immune Globulin Market players such as ADMA Biologics, Bio Products Laboratory, Grifols, Biotest AG, CSL Behring, FFF Enterprises, Cleveland Clinic, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What are the major applications of the Hepatitis B Immune Globulin Market?
Depending upon the type of applications, the Hepatitis B Immune Globulin Market has been segmented into and other applications.
What is the estimated size & growth rate of the Hepatitis B Immune Globulin Market?
In recent years, the Hepatitis B Immune Globulin Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What are the underlying opportunities in the Hepatitis B Immune Globulin Market?
The influx of capital into the Hepatitis B Immune Globulin Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
How is the competitive landscape for the Hepatitis B Immune Globulin Market defined?
Companies in the Hepatitis B Immune Globulin Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Hepatitis B Immune Globulin Market's trajectory and future outlook.